Related Experiment Video
Updated: May 12, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Increased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitus
Hui Zhang1, Chun Gao, Long Fang
1Department of Gastroenterology, China-Japan Friendship Hospital, Ministry of Health, Beijing 100029, China.
Insights
Hepatocellular carcinoma (HCC) patients with diabetes mellitus (DM) showed increased international normalized ratio (INR) levels. These findings suggest closer monitoring of coagulation function in diabetic HCC patients is clinically important.
Area of Science:
- Hepatology and Oncology
- Endocrinology and Metabolism
Background:
- Hepatocellular carcinoma (HCC) is a significant global health concern.
- Diabetes Mellitus (DM) is a common comorbidity in HCC patients, potentially influencing disease progression and management.
Purpose of the Study:
- To investigate the association between diabetes mellitus (DM) and international normalized ratio (INR) levels in patients diagnosed with hepatocellular carcinoma (HCC).
- To determine if DM is an independent predictor of altered INR levels in HCC patients.
Main Methods:
- Retrospective analysis of 375 HCC patients' demographic, clinical, and laboratory data.
- Statistical comparisons using Chi-squared, Student's t-test, and Mann-Whitney U tests.
- Multivariable logistic regression and subgroup analyses were employed to assess the association between DM and INR, controlling for confounding factors like liver cirrhosis and HBV infection.
Main Results:
- Diabetic HCC patients (16.8%) exhibited significantly higher INR levels (1.31 ± 0.44 vs. 1.18 ± 0.21, P = 0.001) compared to non-diabetic patients.
- After adjusting for confounding variables, DM remained an independent predictor of elevated INR (OR = 3.650; P = 0.010), a finding consistent in subgroup analysis of cirrhotic patients (OR = 5.161; P = 0.006).
- No significant correlation was observed between INR levels and fasting glucose or diabetes duration/treatment, except for age at diagnosis.
Conclusions:
- Diabetes mellitus is associated with increased international normalized ratio (INR) levels in hepatocellular carcinoma patients.
- Elevated INR in diabetic HCC patients warrants close monitoring of coagulation function in clinical practice.
Aim:
To determine the association of diabetes mellitus (DM) and international normalized ratio (INR) level in hepatocellular carcinoma (HCC) patients.
Methods:
Our present study included 375 HCC patients who were treated at the China-Japan Friendship Hospital, Ministry of Health (Beijing, China), in the period from January 2003 to April 2012, and with a hospital discharge diagnosis of HCC. The demographic, clinical, laboratory, metabolic and instrumental features were analyzed. χ² test, Student's t test and Mann-Whitney U test were used to compare the differences between HCC patients with and without DM. Unconditional multivariable logistic regression analysis was used to determine the association of DM and INR level in HCC patients. A sub-group analysis was performed to assess the effect of liver cirrhosis or hepatitis B virus (HBV) infection on the results. The Pearson correlation test was used to determine the relationship between INR level and fasting glucose. In addition, association between diabetes duration, and diabetes treatment and INR level was determined considering the potentially different effects.
Results:
Of the total, 63 (16.8%) patients were diabetic (diabetic group) and 312 (83.2%) patients were diagnosed without diabetes (non-diabetic group). Their mean age was 56.4 ± 11.0 years and 312 (83.2%) patients were male. Compared with patients without DM, the HCC patients with diabetes were older (59.5 ± 10.3 vs 55.8 ± 11.1, P = 0.015), had a lower incidence of HBV infection (79.4% vs 89.1%, P = 0.033), had increased levels of systolic blood pressure (SBP) (133 ± 17 vs 129 ± 16 mmHg, P = 0.048) and INR (1.31 ± 0.44 vs 1.18 ± 0.21, P = 0.001), had lower values of hemoglobin (124.4 ± 23.9 vs 134.2 ± 23.4, P = 0.003) and had a platelet count (median/interquartile-range: 113/64-157 vs 139/89-192, P = 0.020). There was no statistically significant difference in the percentages of males, overweight or obesity, drinking, smoking, cirrhosis and Child classification. After controlling for the confounding effects of age, systolic blood pressure, hemoglobin, platelet count and HBV infection by logistic analyses, INR was shown as an independent variable [odds ratio (OR) = 3.650; 95%CI: 1.372-9.714, P = 0.010]. Considering the effect of liver cirrhosis on results, a sub-group analysis was performed and the study population was restricted to those patients with cirrhosis. Univariate analysis showed that diabetic patients had a higher INR than non-diabetic patients (1.43 ± 0.51 vs 1.25 ± 0.23, P = 0.041). After controlling for confounding effect of age, SBP, hemoglobin, platelet count and HBV infection by logistic analyses, INR level remained as the sole independent variable (OR = 5.161; 95%CI: 1.618-16.455, P = 0.006). No significant difference in the relationship between INR level and fasting glucose was shown by Pearson test (r = 0.070, P = 0.184). Among the 63 diabetic patients, 35 (55.6%) patients had been diagnosed with DM for more than 5 years, 23 (36.5%) received oral anti-diabetic regimens, 11 (17.5%) received insulin, and 30 (47.6%) reported relying on diet alone to control serum glucose levels. No significant differences were found for the association between DM duration/treatment and INR level, except for the age at diabetes diagnosis.
Conclusion:
The INR level was increased in HCC patients with DM and these patients should be monitored for the coagulation function in clinical practice.
Related Concept Videos
Hyperglycemia
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Diabetic Retinopathy
Diabetic Nephropathy